Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-05-05 @ 12:58 PM
Study NCT ID:
NCT01011933
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2009-11-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2011-01958
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |